Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity

Research output: Contribution to journalEditorialpeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)549-552
Number of pages4
JournalExpert Opinion on Drug Safety
Volume18
Issue number7
DOIs
StatePublished - Jul 3 2019
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Keywords

  • Bupropion
  • contrave
  • naltrexone
  • obesity
  • opioid resistant analgesia
  • psoriasis

Cite this